• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Biogen's Alzheimer's drug aducanumab, if approved, may face extra hurdles, slow sales ramp: analysts